Search details
1.
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy.
J Immunol
; 212(6): 1002-1011, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38294274
2.
Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response.
Proc Natl Acad Sci U S A
; 120(25): e2304445120, 2023 06 20.
Article
in English
| MEDLINE | ID: mdl-37307479
3.
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med
; 387(21): 1957-1968, 2022 11 24.
Article
in English
| MEDLINE | ID: mdl-36346079
4.
Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
Gastroenterology
; 167(2): 357-367.e9, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38513745
5.
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis B.
Eur J Immunol
; : e2451085, 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38813721
6.
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials.
Hepatology
; 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38630448
7.
B cell activation gene signature in blood and liver of HBeAg+ immune active chronic hepatitis B patients.
J Infect Dis
; 2024 Jun 07.
Article
in English
| MEDLINE | ID: mdl-38847286
8.
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
J Hepatol
; 80(2): 243-250, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37898348
9.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38483300
10.
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
J Viral Hepat
; 31(4): 197-207, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38243144
11.
Use of HBV RNA and to predict change in serological status and disease activity in CHB.
Hepatology
; 78(5): 1542-1557, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37074026
12.
Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.
Hepatology
; 78(5): 1525-1541, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37158243
13.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36697207
14.
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(12): 3089-3096.e1, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37004973
15.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Article
in English
| MEDLINE | ID: mdl-35863683
16.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34762906
17.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Gastroenterology
; 163(6): 1630-1642.e3, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36150526
18.
Association of Alanine Aminotransferase Flares to Hepatitis B Surface Decline During Tenofovir Alone or With Pegylated Interferon Alfa.
Am J Gastroenterol
; 118(11): 2075-2079, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37307571
19.
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.
Am J Gastroenterol
; 118(7): 1226-1236, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36728214
20.
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
Am J Gastroenterol
; 118(7): 1214-1225, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36599136